1. Home
  2. PRGO

as 11-15-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Founded: 1887 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN 2
Market Cap: 3.6B IPO Year: 1991
Target Price: $37.00 AVG Volume (30 days): 1.9M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
4.12%
Dividend Payout Frequency: Quarterly
EPS: -1.17 EPS Growth: N/A
52 Week Low/High: $23.89 - $34.60 Next Earning Date: 11-06-2024
Revenue: $4,392,000,000 Revenue Growth: -5.63%
Revenue Growth (this year): -2.81% Revenue Growth (next year): 4.51%

PRGO Daily Stock ML Predictions

Stock Insider Trading Activity of Perrigo Company plc (PRGO)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Doyle Katherine C. PRGO Director Sep 13 '24 Sell $27.30 8,954 $244,444.20 6,009
Janish Ronald Craig PRGO EVP, Gbl Ops & SC & CTO Aug 26 '24 Sell $29.40 13,000 $382,245.50 20,553
Andersen Svend PRGO EVP & President CHCI Aug 20 '24 Sell $27.58 34,983 $968,560.28 81,353

Share on Social Networks: